Please login to the form below
Lexapro
This page shows the latest Lexapro news and features for those working in and with pharma, biotech and healthcare.
Lundbeck and Otsuka start phase III for Rexulti in bipolar
protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).
Latest news
-
Lundbeck and Otsuka's Rexulti set for August launch in US
which it hopes will restore growth after the loss of patent protection on US blockbuster antidepressant Lexapro/Celexa (escitalopram).
-
NICE backs drug to cut alcohol consumption
its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
-
NICE recommends Lundbeck’s alcohol dependency drug
Lundbeck has high hopes for Selincro as it tries to overcome the impact of the loss of patent protection for its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
-
Lundbeck launches Brintellix in first EU market
The first EU launch of Brintellix is another important step for the Danish company as it recovers from the loss of patent protection for its antidepressant Lexapro (escitalopram oxalate), a former ... Clinical trial results suggest Brintellix is at least
-
NICE backs Lundbeck's alcohol dependence drug Selincro
selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
More from news
Approximately 2 fully matching, plus 29 partially matching documents found.
Latest Intelligence
-
Pharma deals during February 2014
given the loss of patent protection on Forest's best selling depression drug Lexapro and another patent cliff looming for Nameda, its Alzheimer's drug in 2015.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- My journey advancing the science in pulmonary hypertension
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
Viseven
Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
